News & Updates
Filter by Specialty:
Modified CXI predicts survival in CRC after surgery
The modified cachexia index (mCXI) is effective in predicting the survival outcomes in patients with colorectal cancer (CRC) following radical surgery, reports a study.
Modified CXI predicts survival in CRC after surgery
06 Nov 2024
Pegaspargase biosimilar safe to use in childhood ALL
The biosimilar Pegaspargase, when combined with chemotherapy, demonstrates a favourable safety profile in children with acute lymphoid leukemia (ALL) treated according to ICiCLe ALL-14 protocol, a study has shown.
Pegaspargase biosimilar safe to use in childhood ALL
05 Nov 2024
Healthy eating may hold back prostate cancer progression
Sticking to a diet that follows the American dietary guideline recommendations may forestall the potential for low-grade prostate cancer to progress to high-grade disease, as suggested in a study.
Healthy eating may hold back prostate cancer progression
26 Oct 2024
Optimal glycaemic control reduces risk of HCC and liver-related mortality in patients with DM
A population-based study of 146,430 Hong Kong patients with diabetes mellitus (DM) reports that optimal vs suboptimal glycaemic control is associated with reduced risk of developing hepatocellular carcinoma (HCC) and liver-related mortality.
Optimal glycaemic control reduces risk of HCC and liver-related mortality in patients with DM
24 Oct 2024
Statins counter heart risks in breast cancer radiotherapy
For patients with breast cancer undergoing adjuvant radiotherapy, statin therapy appears to confer cardioprotective effects, mitigating the risk of major adverse cardiovascular event, according to a retrospective study.